An interventional study of SickleFit Exercise plus Nutrition in Sickle Cell Disease and Aging, sponsored by Duke University. Recruiting at 1 site in United States. Open to participants aged 35 Years and older. Per ClinicalTrials.gov, last updated 2026-05-07.
Sponsored by Duke University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Anemia, Sickle Cell by Duke University — 2 open to participants now, 2 under way, none of them phase 3. Anemia, Sickle Cell · Duke University.
Among the 25 studies in Anemia, Sickle Cell by Duke University, this one is the 10th largest by planned enrollment of the 19 interventional ones that give a count, is the only one that started in 2026, is one of 14 with no phase, and was the 25th registered.
1,136 studies on the registry are indexed under Anemia, Sickle Cell; 240 are open to participants now.
Browse Anemia, Sickle Cell studies →2 of the 25 studies in Anemia, Sickle Cell by Duke University are open now, in 1 country. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 15–40
By country, each count listing its studies:
Of the 177 Anemia, Sickle Cell studies recruiting now, 64 (36%) set no upper age limit and 97 (55%) stop at 75 or younger; 127 take children under 18; 29 take healthy volunteers.
This study: 35 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is close to the median of 40 across 770 interventional studies indexed under Anemia, Sickle Cell.
Median enrollment 40 across the 19 interventional studies, 158 across the 6 observational. Of the 23 that completed or were terminated, 7 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 25 studies in Anemia, Sickle Cell by Duke University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial
Investigators will pilot the SickleFit personalized exercise plus dietitian-facilitated nutrition intervention randomized control trial in adults (age ≥ 35 years) with sickle cell disease.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in SickleFit arm will complete the Sickle Cell Disease Functional Assessment before and after 12 weeks of SickleFit exeercise+Nutrition intervention.
Behavioral: SickleFit Exercise plus Nutrition
Participants in the control arm will be on a wait list for SickleFit and will continue to receive usual care during that 12-week period. They will complete the Sickle Cell Disease Functional Assessment at baseline and after 12 weeks on the wait list. After their post-assessment, they will have the option to complete 12 weeks of SickleFit exercise+Nutrition intervention.
SickleFit personalized exercise plus dietitian-facilitated nutrition intervention
Feasibility of Randomization
Feasibility of randomization (proportion of participants randomized out of those approached)
Time frame: From enrollment to the last paticipants randomized over a 2 year period
Safety/Adverse Events
number of life-threatening adverse events
Time frame: adverse events will be measured for both arms up to 6 months
Acceptability
Proportion of participants reporting satisfaction with the program
Time frame: From enrollment to after completion of the SickleFit Program over 6 months since we will also measure acceptability for control group
Retention in the program
retention (proportion of the SickleFit and control groups completing follow up assessment)
Time frame: From the baseline Sickle Cell Disease Functional Assessment to the post-SCD-FA. Over a 30 week period since post assessments will be completed within 3 months of completion of the SickleFit program or control period.
Adherence
Adherence (proportion attending ≥ 50% of classes) in the SickleFit arm
Time frame: From the start of the first SickleFit session to the end of the SickleFit program at 12 weeks
Performance on the Sickle Cell Disease Functional Assessment (SCD-FA)
Change in physical performance and patient-reported outcomes on the Sickle Cell Disease Functional Assessment (SCD-FA)
Time frame: From baseline assessment to completion of the post-assessment within 6 months
Plan to share: No
Started Apr 2026 (actual). Primary completion is estimated for Jan 2028, 21 months after the start.
Of 165 non-industry interventional studies with no phase under Anemia, Sickle Cell, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 54. This study's planned 21 months is below that.
Counting every sponsor, half of 173 studies reached it within 28 months; a quarter within 15 and three quarters within 49.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.